Literature DB >> 959582

Indomethacin potentiates the vasoconstrictor actions of angiotensin II in normal man.

P Negus, R L Tannen, M J Dunn.   

Abstract

The blood pressure response to graded infusions of angiotensin II was assessed under control conditions and following short term (16 hour) indomethacin treatment utilizing normal men equilibrated on a constant diet of normal sodium and potassium content. Although basal mean blood pressure was unchanged, the increase in blood pressure with all rates of angiotensin II infusion ranging from 200 to 1000 ng/min was significantly greater with indomethacin treatment. Pre-infusion body weight and plasma renin activity were similar under the two conditions. These results suggest that prostaglandins modulate the systemic vasoconstrictor effects of angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 959582     DOI: 10.1016/0090-6980(76)90111-8

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  16 in total

1.  A comparison of the haemodynamic and hormonal effects of low and conventional dose cyclopenthiazide in normal volunteers.

Authors:  G E McVeigh; M McMaster; T Linton; E Whitehead; G D Johnston
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin.

Authors:  M J Webberley; J A Murray
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

Review 3.  The neuroendocrine response to multiple trauma.

Authors:  D S Gann; M P Lilly
Journal:  World J Surg       Date:  1983-01       Impact factor: 3.352

4.  Adverse effects of NSAIDs on renal function.

Authors:  A L Linton
Journal:  Can Med Assoc J       Date:  1984-08-01       Impact factor: 8.262

5.  Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.

Authors:  Youfei Guan; Yahua Zhang; Jing Wu; Zhonghua Qi; Guangrui Yang; Dou Dou; Yuansheng Gao; Lihong Chen; Xiaoyan Zhang; Linda S Davis; Mingfeng Wei; Xuefeng Fan; Monica Carmosino; Chuanming Hao; John D Imig; Richard M Breyer; Matthew D Breyer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

6.  Arachidonic acid metabolites, hypertension and arteriosclerosis.

Authors:  P C Weber; W Siess; B Scherer; E Held; H Witzgall; R Lorenz
Journal:  Klin Wochenschr       Date:  1982-05-17

7.  Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins.

Authors:  D I Diz; P G Baer; A Nasjletti
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

8.  Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition.

Authors:  P Minuz; P Pancera; M Ribul; F Priante; M Degan; A Campedelli; E Arosio; A Lechi
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

9.  Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy.

Authors:  M B Finch; G D Johnston; J G Kelly; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

10.  Mechanism of decreased vascular reactivity to angiotensin II in conscious, potassium-deficient rats.

Authors:  M S Paller; J G Douglas; S L Linas
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.